concerns about heart failure with Avandia and Actos

October 2001

There are growing concerns about heart failure with Avandia and Actos.

This is not a complete surprise. Warnings already exist in the Canadian labelling.

Now stronger warnings are being added to the U.S. labelling for Avandia.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

healthcare professionals are being asked to develop bioterrorism protocols
more aggressive guidelines for diabetes screening and management
Gastroenterology new proton pump inhibitor called Nexium (esomeprazole)
Women's Health two new transdermal estrogen systems, Estradot and Estalis Sequi
Women's Health if it's okay to drink a little alcohol occasionally during pregnancy
Diabetes new rapid-acting insulin analog called NovoRapid (insulin aspart)
Diabetes concerns about heart failure with Avandia and Actos
Men's Health whether Viagra (sildenafil) loses its effectiveness over time
Men's Health which BPH patients should get Proscar or an alpha-blocker
withdrawal symptoms when patients stop antidepressants
Topamax might cause vision problems
Pediatrics amantadine for children with autism or other developmental disabilities
Pediatrics Lamictal now comes in a new 2 mg chewable tab for young children
Infectious Diseases Cancidas (can-SIGH-das), a new IV antifungal agent
Infectious Diseases Remicade and Enbrel could lead to increases in tuberculosis (TB)
Natural Medicines glutamine for mucositis caused by chemotherapy
Natural Medicines Our CE Booklets on natural medicines
Antithrombotics whether patients need additional monitoring if they're switched from Coumadin to one of the generics